Cipla Q3 Results
- BSE: 500087
- NSE: CIPLA
- ISIN: INE059A01026
- Sector: Biotechnology & Drugs
BSE
1,658.75
1.65 (0.10%)
1.65 (0.10%)Volume7.05 K
Updated: Fri 13 Sep, 2024 | 15:29:54
NSE
1,659.72.45 (0.15%)
2.45 (0.15%)Volume7.47 L
Updated: Fri 13 Sep, 2024 | 15:58:51
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Cipla Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 23 | Sep 23 | QoQ Comp | Dec 22 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 6,603.81 | 6,678.15 | -1.11% | 5,810.09 | 13.66% |
| Selling/ General/ Admin Expenses Total | 1,068.13 | 1,091.10 | -2.11% | 948.69 | 12.59% |
| Depreciation/ Amortization | 233.43 | 290.04 | -19.52% | 272.11 | -14.21% |
| Other Operating Expenses Total | 1,568.62 | 1,540.21 | 1.84% | 1,449.55 | 8.21% |
| Total Operating Expense | 5,284.53 | 5,234.44 | 0.96% | 4,674.65 | 13.05% |
| Operating Income | 1,319.28 | 1,443.71 | -8.62% | 1,135.44 | 16.19% |
| Net Income Before Taxes | 1,473.81 | 1,594.23 | -7.55% | 1,218.06 | 21.00% |
| Net Income | 1,055.90 | 1,130.91 | -6.63% | 800.96 | 31.83% |
| Diluted Normalized EPS | 14.82 | 14.00 | 5.85% | 9.92 | 49.38% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01Stocks to buy for long term: HDFC Bank, SBI...Nirmal Bang recommends these 5 shares to buy, expects 9-61% upside
4 min read15 Sep 2024 - Markets
02Buy or sell: From Airtel to Tata Steel — Ganesh Dongre recommends three stocks for Monday
3 min read15 Sep 2024 - Markets
03Arkade Developer IPO opens tomorrow. GMP, review, other details in 10 points
2 min read15 Sep 2024